Showing posts with label drug discovery. Show all posts
Showing posts with label drug discovery. Show all posts
Tuesday, March 11, 2025

Nvidia's interest and investment in Recursion Pharmaceuticals (RXRX) in 2025 could be a game changer for this small-cap!

›
    Recursion Pharmaceuticals (NASDAQ: RXRX) is a clinical-stage biotechnology company that integrates advanced technologies across biology...
Tuesday, February 18, 2025

Will 2025 bring a buyout offer for Viking Therapeutics and their cutting edge drug pipeline? Stay tuned!

›
  Viking Therapeutics (VKTX) – Investment & Business Report (February 2025) Company Overview Viking Therapeutics, Inc. (NASDAQ: VKTX) is...
Wednesday, July 10, 2024

Two years ago! That was the last time you could buy shares of Recursion Pharmaceuticals (NASDAQ: RXRX) at today's price! Here's why!

›
  Recursion Pharmaceuticals (NASDAQ: RXRX)   recently raised approximately $200 million through a public offering of 30,769,230 shares of it...
Friday, June 21, 2024

Pfizer is actively using artificial intelligence (AI) and machine learning (ML) to enhance its drug development processes.

›
   Pfizer has integrated AI in various stages of drug discovery and development to accelerate research and improve precision. One of the sig...

Quantum annealing technology has real world benefit for both businesses and society in general!

›
  Quantum annealing is a quantum computing technique designed to solve optimization problems faster than classical algorithms. It leverages ...
Sunday, May 12, 2024

Recursion Pharmaceuticals is at the forefront of AI-driven drug discovery!

›
  Recursion Pharmaceuticals  has caught the attention of major pharmaceutical companies due to its innovative approach to drug discovery. Mo...